BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers
about
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers
description
2020 nî lūn-bûn
@nan
2020年の論文
@ja
2020年学术文章
@wuu
2020年学术文章
@zh
2020年学术文章
@zh-cn
2020年学术文章
@zh-hans
2020年学术文章
@zh-my
2020年学术文章
@zh-sg
2020年學術文章
@yue
2020年學術文章
@zh-hant
name
BRCAness, SLFN11, and RB1 loss ...... triple-negative breast cancers
@en
type
label
BRCAness, SLFN11, and RB1 loss ...... triple-negative breast cancers
@en
prefLabel
BRCAness, SLFN11, and RB1 loss ...... triple-negative breast cancers
@en
P2093
P50
P1476
BRCAness, SLFN11, and RB1 loss ...... triple-negative breast cancers
@en
P2093
Adrien Briaux
Agnès Noel
Ahmed Dahmani
Anne Salomon
Cécile Reyes
Didier Decaudin
Elodie Montaudon
Fabien Reyal
Fariba Nemati
Georges Lucotte
P356
10.1126/SCITRANSLMED.AAX2625
P50
P577
2020-02-01T00:00:00Z